Continue with FacebookLooking to list your PhD opportunities? Log in here.
We have 26 colorectal cancer PhD Projects, Programmes & Scholarships
colorectal cancer PhD Projects, Programmes & Scholarships
We have 26 colorectal cancer PhD Projects, Programmes & Scholarships
PhD saved successfully
Biological significance, predictive value and targeting of cell surface antigens in colorectal cancer.
Despite major advances in its early detection, preventive measures and therapeutic options, colorectal cancer is the fourth most commonly diagnosed cancer and the third leading cause of cancer deaths worldwide. Read more
Screening, prevention and diagnosis of colorectal cancer
PhD Studentship in Cancer Epidemiology. Department of Surgery and Cancer. Imperial College London. St Mary’s Campus, Paddington, London, UK. Read more
Utilising administrative data to inform FIT-guided suspected colorectal cancer referrals of symptomatic patients
Commercial partner: Alpha Laboratories Ltd. Colorectal cancer (CRC) is the third leading cause of cancer death worldwide. In the UK, around 43,000 new CRC cases are recorded annually, and its comparatively high incidence and mortality represent a considerable public health burden. Read more
Investigating the effects of secreted microbial metabolites produced under acid conditions on colorectal cancer cell growth
Colorectal cancer (CRC) is one of the three leading killer cancers worldwide and has a low therapeutic index of therapy. The initiation and progression of CRC is modulated by the gut microbiota and metabolites they produce. Read more
The paradox of AMER1 driver mutations in colorectal cancer
Cancer develops in part owing to somatic mutations acquired by so-called driver genes. About 90% of colorectal cancers are caused by mutations in the classical tumour suppressor gene, APC. Read more
Cancer: Epigenetic therapy using microbubble-mediated drug delivery for colorectal cancer
The project is an interdisciplinary, pre-clinical study that aims to investigate the response of human tumour cells to treatment with epigenetic inhibitors (including DNA methyltransferase inhibitors, HDAC inhibitors and/or vitamin C), as a potential combination therapy for colorectal cancer (CRC). Read more
Oncology: Evaluating Photodynamic Therapy in colorectal cancer using patient-derived organoids
Colorectal cancer (CRC) is the 3rd most common cancer worldwide. Surgery is first line treatment and often in adjunct with chemotherapy. Read more
Investigating the role of dietary fructose in the development of early-onset colorectal cancer
IMPORTANCE. This project will investigate the role of fructose in the development of colorectal cancer (CRC) in adults <50 years (early-onset CRC, EOCRC). Read more
Development of a Low-Cost Autonomous Device for Colorectal Cancer Screening and Treatment
We are excited to announce a fantastic opportunity to join our dynamic team at the Endorobotics Lab, led by Dr. Luigi Manfredi, in the School of Medicine at the University of Dundee. Read more
Investigating the penetrance of cancer susceptibility genes in a population cohort and the influences of family history and rare and common genetic modifiers. MRC GW4 BioMed DTP PhD studentship 2024/25 Entry, PhD in Clinical and Biomedical Sciences
About the GW4 BioMed2 Doctoral Training Partnership. The partnership brings together the Universities of Bath, Bristol, Cardiff (lead) and Exeter to develop the next generation of biomedical researchers. Read more
Translational Medicine: Understanding the mechanism(s) of resistance to EPA to personalise therapy and improve outcome
Advanced colorectal cancer (CRC) is the UK’s second most lethal cancer, with limited treatment options for unresectable metastatic tumours. Read more
Estimating the global cancer burden due to low levels of physical activity
The student will estimate the overall global burden of cancer risk which is due to low levels of physical activity using a combination of. Read more
Repurposing and enriching cardiovascular risk prediction model to identify people at risk of cancer – UCL (part of Health Data Research UK’s Big Data for Complex Disease Driver Programme)
Risk-stratified management of cardiovascular disease (CVD), where people without established disease receive preventative interventions and monitoring based on their 10-years predicted risk, has been highly successful to ensure healthcare resources are allocated to those most likely to benefit. Read more
Investigation of Cancer-Associated Fibroblast Self-directed Matrices to Inform Therapeutic Approaches to Refractory Cancers
Fixed term contract for 3 years, commencing January 2024. Bursary of £ 18,622 per annum and a full fee-waiver for UK tuition fees. Read more
Endosomal Sorting Complex Required for Transport (ESCRT): Investigation of the role in acquired drug resistance in colon cancer
Research Group:
Institute of Cancer Therapeutics
Despite treatment advances, one of the most common cancers, colorectal cancer (CRC), still has a 45% mortality rate, and one of the major problems is the build-up of resistance to cancer drugs during treatment (‘acquired resistance’) such that over time the drugs stop working. Read more
- 1
- 2